Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Mini Oral session - Sarcoma

The efficacy of eribulin methylate for patients with taxane-resistant cutaneous angiosarcoma: Final results from a multi-center, prospective, observational study

Date

22 Nov 2019

Session

Mini Oral session - Sarcoma

Presenters

Yasuhiro Fujisawa

Citation

Annals of Oncology (2019) 30 (suppl_9): ix135-ix139. 10.1093/annonc/mdz433

Authors

Y. Fujisawa1, K. Yoshino2, T. Fujimura3, Y. Yamamoto4, H. Uchi5, H. Hata6, A. Otsuka7, T. Miyagi8, T. Funakoshi9, S. Matsushita10

Author affiliations

  • 1 Dermatology, University of Tsukuba, 3058577 - Tsukuba/JP
  • 2 Dermatology, Komagome Hospital, Tokyo/JP
  • 3 Dermatology, Tohoku University, Sendai/JP
  • 4 Dermatology, Wakayama Medical University, Wakayama/JP
  • 5 Dermatology, Kyushu University, Hakata/JP
  • 6 Dermatology, Hokkaido University, Sapporo/JP
  • 7 Dermatology, Kyoto University-Graduate school of medicine, 606-8507 - Kyoto/JP
  • 8 Dermatology, Ryukyu University, Naha/JP
  • 9 Dermatology, Keio University, Tokyo/JP
  • 10 Department Of Dermato-oncology/dermatology, National Hospital Organization Kagoshima Medical Center, Kagoshima/JP
More

Resources

Login to access the resources on OncologyPRO.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings